Steel N R, Taylor J J, Holcombe M, Weightman D R, Kendall-Taylor P
Department of Medicine, Royal Victoria Infirmary, Newcastle upon Tyne, UK.
Autoimmunity. 1988;1(2):81-90. doi: 10.3109/08916938809001921.
Antibodies that inhibit the stimulation of the thyroid by TSH have been studied in 63 patients with primary hypothyroidism of whom 34 had thyroid atrophy and 29 goitrous Hashimoto's thyroiditis. The method used measured the secretion of tri-iodothyronine (T3) from porcine thyroid slices incubated in vitro. The aims of the study were to assess the frequency and clinical correlates of blocking antibodies in an unselected series of patients, to establish their IgG nature and to examine their action in relation to the TSH receptor. Blocking antibodies were found in 25% of patients and occurred in association with both atrophic (32%) and goitrous (17%) hypothyroidism. These antibodies did not bind TSH (with one exception) nor did they inhibit binding of TSH to its receptor (also with one exception). Blocking-antibody activity was abolished by treatment of the serum with anti-hIgG or with protein A, and the activity was purified from serum by affinity chromatography on protein A sepharose-4B, thus establishing the IgG nature of the antibodies. The stimulation of T3 secretion by thyroid-stimulating antibodies was also blocked and in one case, where IgG did not block stimulation by bTSH, stimulation by hTSH was blocked. Antibodies blocking the action of TSH probably represent an important mechanism in the pathogenesis of primary hypothyroidism in some patients.
对63例原发性甲状腺功能减退症患者进行了研究,这些患者体内存在抑制促甲状腺激素(TSH)刺激甲状腺的抗体,其中34例有甲状腺萎缩,29例有桥本甲状腺炎伴甲状腺肿大。所采用的方法是测定体外培养的猪甲状腺切片中三碘甲状腺原氨酸(T3)的分泌量。该研究的目的是评估在一组未经挑选的患者中阻断抗体的发生率及其临床相关性,确定其免疫球蛋白G(IgG)的性质,并研究其与TSH受体相关的作用。在25%的患者中发现了阻断抗体,且同时存在于萎缩性甲状腺功能减退症患者(32%)和桥本甲状腺炎伴甲状腺肿大的患者(17%)中。这些抗体不与TSH结合(仅1例除外),也不抑制TSH与其受体的结合(同样仅1例除外)。用抗人IgG或蛋白A处理血清可消除阻断抗体活性,并且通过蛋白A琼脂糖-4B亲和层析从血清中纯化该活性,从而确定了抗体的IgG性质。促甲状腺抗体对T3分泌的刺激作用也受到阻断,在1例中,IgG不能阻断牛促甲状腺激素(bTSH)的刺激作用,但能阻断人促甲状腺激素(hTSH)的刺激作用。阻断TSH作用的抗体可能是部分原发性甲状腺功能减退症患者发病机制中的一个重要因素。